Platform strategy · Updated October 4, 2026
Build vs. buy a telehealth platform.
The decision is not simply custom software versus a subscription. It is a choice about operating responsibility, control, implementation burden, maintenance, integrations, governance, and the relationships required to support care.
01
Start with the capabilities the business must own.
List the experiences and assets that are strategically differentiating: brand, audience, acquisition, customer relationship, data portability, and selected workflows. Do not custom-build commodity functions merely to create the appearance of control.
02
Count implementation and maintenance—not only licensing.
A build path requires product ownership, security, reliability, integrations, support, updates, and governance. A partner path reduces some burdens but creates dependencies that should be explicit in contracts, service expectations, and exit planning.
03
Separate technology from regulated roles.
Owning software does not create clinical authority or a pharmacy relationship. Evaluate the platform, non-clinical services, independent clinician access, professional entity requirements, and pharmacy pathways as distinct layers.
04
Test integration and data portability early.
Ask which systems are authoritative, which integrations are standard or custom, how events and records move, what can be exported, and what happens if the relationship ends. A migration question asked before launch is cheaper than one asked during an exit.
05
Use a weighted decision record.
Score each option against control, launch dependencies, internal staffing, privacy and security responsibilities, scalability, support, data rights, and total cost. Record assumptions and the evidence behind them so the decision can be revisited as the business changes.